Tabula Rasa HealthCare, Inc. revised preliminary revenue guidance for the fourth quarter 2022 . Revenue from continuing operations for the fourth quarter of 2022 is expected to be between $82 $83 million, exceeding the prior guidance range of $77.5 $80.5 million.
Tabula Rasa HealthCare, Inc.
Equities
TRHC
US8733791011
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
-4.29% | 2.98TCr | |
+44.14% | 969.41Cr | |
+36.80% | 449.68Cr | |
-37.06% | 238.41Cr | |
-8.01% | 162.92Cr | |
-30.32% | 120.41Cr | |
+6.59% | 95Cr | |
-41.51% | 99Cr | |
-45.19% | 76Cr |